MED2C
Annual accounts 2025
financial year from 01-10-2024 to 31-12-2025, 15 months, micro format, filed on 31-07-2026, on the day of the deadline€22,075
€19,297
€13,699
€15,739
66.3%
2.98
Turnover is estimated at about €160,000, probably between €74,000 and €390,000. The micro format does not state turnover.
Balance sheet
balance sheet total €23,679 on 31-12-2025What the company ownsHow it is paid for
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 202515 months |
|---|---|---|
| 22,075 | ||
| 16,477 | ||
| 15,739 | ||
| 66.3% | ||
| 2.98 | ||
| 0.51 | ||
| 87.3% | ||
| 57.9% | ||
| over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 202515 months |
|---|---|---|
| Balance sheet: assets | ||
20/58 |
23,679 | |
29/58 |
23,679 | |
54/58 |
23,679 | |
| Balance sheet: equity and liabilities | ||
10/49 |
23,679 | |
10/15 |
15,699 | |
10/11 |
2,000 | |
13 |
13,699 | |
133 |
13,699 | |
17/49 |
7,980 | |
42/48 |
7,940 | |
44 |
363 | |
440/4 |
363 | |
45 |
2,542 | |
450/3 |
2,542 | |
47/48 |
5,035 | |
492/3 |
39 | |
| Income statement | ||
9900 |
22,075 | |
630 |
2,778 | |
9901 |
19,297 | |
65/66B |
56 | |
65 |
56 | |
9903 |
19,241 | |
67/77 |
5,542 | |
9904 |
13,699 | |
9905 |
13,699 | |
| Appropriation of the result | ||
9906 |
13,699 | |
691/2 |
13,699 | |
6921 |
13,699 | |
| Document | ||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 31-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 31-07-2026 | 2026-00387693 |
Insights on MED2C
Debt's share of the balance-sheet total is 33.7%.